Page last updated: 2024-08-24
telmisartan and 9,10-epoxy-12-octadecenoate
telmisartan has been researched along with 9,10-epoxy-12-octadecenoate in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Angioni, C; de Bruin, N; Geisslinger, G; Hofmann, M; Hohman, SW; Ji, RR; Jordan, H; Kuzikov, M; Liu, D; Lu, R; Meyer Dos Santos, S; Park, CK; Parnham, MJ; Schäfer, SM; Schmidt, M; Scholich, K; Schreiber, Y; Sisignano, M; Suo, J; Woolf, CJ; Yekkirala, AS; Zhang, DD; Zimmer, B; Zinn, S | 1 |
Other Studies
1 other study(ies) available for telmisartan and 9,10-epoxy-12-octadecenoate
Article | Year |
---|---|
Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents, Phytogenic; Benzimidazoles; Benzoates; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Female; Ganglia, Spinal; Gene Expression Regulation, Enzymologic; HEK293 Cells; Humans; Linoleic Acids; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Neuralgia; Paclitaxel; Pain Threshold; Telmisartan | 2016 |